Primary Amenorrhea with Absent Uterus: Differential Diagnosis and Work-Up
When a patient presents with primary amenorrhea and an absent uterus, the three primary diagnoses to consider are Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, Complete Androgen Insensitivity Syndrome (CAIS), and ovotesticular disorder of sex development (DSD), with MRKH being most common (57.4% of cases) followed by CAIS (37.7%) 1.
Critical Initial Caveat
Before assuming true uterine absence, confirm the patient is adequately estrogenized. In hypoestrogenic states (hypogonadotropic hypogonadism, premature ovarian insufficiency), the uterus may be too small to visualize on ultrasound, leading to misdiagnosis of Müllerian agenesis 2, 3. This is a common diagnostic pitfall that can result in incorrect classification and inappropriate management.
Algorithmic Diagnostic Approach
Step 1: Physical Examination - Pubic Hair Pattern
The presence and distribution of pubic hair immediately narrows your differential:
- Absent or sparse pubic hair with normal breast development → CAIS (androgen insensitivity prevents pubic/axillary hair growth) 1
- Normal pubic hair and breast development → MRKH syndrome or ovotesticular DSD 1
Step 2: Vaginal Length Assessment
Measure vaginal depth during pelvic examination:
- Shortest vaginal length → MRKH syndrome 1
- Intermediate vaginal length → CAIS 1
- Variable vaginal length → Ovotesticular DSD 1
Step 3: Hormonal Evaluation
Obtain the following laboratory panel 4:
Essential tests:
- Karyotype (46,XX vs 46,XY)
- Serum testosterone (total)
- FSH and LH
- Estradiol (E2)
- TSH and free T4
- Prolactin
Interpretation patterns:
- Male-range testosterone (>200 ng/dL) with 46,XY karyotype → CAIS 1, 5
- Female-range hormones with 46,XX karyotype → MRKH syndrome 1, 5
- Elevated FSH (>40 IU/L) with low estradiol → Consider gonadal dysgenesis; the uterus may be present but not visualized due to hypoestrogenism 3
- Low FSH and low estradiol → Hypogonadotropic hypogonadism; uterus likely present but too small to visualize 2, 3
- Nonspecific endocrine patterns → Consider ovotesticular DSD 1
Step 4: Imaging Confirmation
Initial imaging:
- Pelvic ultrasound (transabdominal or transvaginal if tolerated) 4
If uterus not visualized and patient is hypoestrogenic:
- Do not conclude Müllerian agenesis 2, 3
- Consider MRI with contrast for better anatomic detail 4
- If hypogonadotropic hypogonadism or premature ovarian insufficiency is suspected, initiate estrogen therapy and repeat imaging after 3-6 months to assess for uterine development 2
If uterus confirmed absent in estrogenized patient:
- Evaluate for renal anomalies (present in >50% of MRKH cases) 2
- Consider skeletal survey if MURCS association suspected 2
Step 5: Definitive Diagnosis
For CAIS (46,XY with male-range testosterone):
- Molecular genetic testing for androgen receptor mutations confirms diagnosis 5
- Consider laparoscopy to locate and remove gonads (malignancy risk) after completion of puberty 5
For MRKH (46,XX with female-range hormones):
- Karyotype confirms 46,XX 5, 6, 7
- Assess for associated renal and skeletal anomalies 2
- No further invasive testing typically needed
For ovotesticular DSD:
- Requires laparoscopy with gonadal biopsy and histomorphological examination for definitive diagnosis 1
- Histology demonstrates both ovarian and testicular tissue
Additional Differential Considerations
While evaluating for absent uterus, also exclude 4:
- Pregnancy (always check β-hCG first)
- Hyperprolactinemia (prolactin >100 ng/mL warrants further evaluation)
- Thyroid dysfunction (TSH with free T4)
- Late-onset congenital adrenal hyperplasia (8 AM 17-hydroxyprogesterone if clinical hyperandrogenism present)
Key Diagnostic Pitfalls to Avoid
Assuming uterine absence in hypoestrogenic patients: In cases with FSH >40 IU/L or FSH <5 IU/L with low estradiol, the uterus may be present but not visualized 2, 3. Treat the underlying condition and repeat imaging.
Missing CAIS in patients with "normal" female appearance: Look specifically for absent/sparse pubic hair despite normal breast development 1.
Failing to check karyotype: Karyotype abnormalities do not exclude MRKH, and 46,XY individuals can present with apparent Müllerian agenesis (actually CAIS or other DSD) 5.
Not screening for renal anomalies in MRKH: Over half have associated renal malformations requiring evaluation 2.
Summary of Diagnostic Features
| Feature | MRKH | CAIS | Ovotesticular DSD |
|---|---|---|---|
| Karyotype | 46,XX | 46,XY | Variable |
| Testosterone | Female range | Male range | Variable |
| Pubic hair | Normal | Absent/sparse | Normal |
| Breast development | Normal | Normal | Normal |
| Vaginal length | Shortest | Intermediate | Variable |
| Associated anomalies | Renal, skeletal | None typical | Variable |
The integrated approach combining clinical phenotype (especially pubic hair pattern), hormonal profile (especially testosterone level), karyotype, and imaging enables accurate differentiation and appropriate management 1.